Literature DB >> 2467705

Human normal CD5+ B lymphocytes can be induced to differentiate to CD5- B lymphocytes with germinal center cell features.

F Caligaris-Cappio1, M Riva, L Tesio, M Schena, G Gaidano, L Bergui.   

Abstract

A significant proportion of cord blood CD5+ B cells express the activation molecules CD23, CD25, and transferrin receptor; react with the cell-cycle-associated monoclonal antibody (MoAb) Ki67; can be induced to enter the S phase of cell cycle by interleukin-2 (IL-2), IL-4, or low-molecular-weight B-cell growth factor (Imw-BCGF) and, exposed to IL-1 and IL-2, acquire the features (sIgD-, CD5-, CD10+, CD38+) of B blasts proliferating in the germinal centers of secondary follicles. These findings indicate that CD5+ B cells are preactivated and, in the proper microenvironment, may give rise to CD5- B cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467705

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.

Authors:  Nicholas Chiorazzi; Manlio Ferrarini
Journal:  Blood       Date:  2010-12-09       Impact factor: 22.113

2.  Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-associated cross-reactive idiotypes.

Authors:  T J Kipps; S F Duffy
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  CD5 expression on B cells may be an activation marker for secretion of anti-myelin antibodies in patients with polyneuropathy associated with monoclonal gammopathy.

Authors:  C Ekerfelt; J Ernerudh; G Solders; M Vrethem
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

4.  CD5-positive and CD5-negative human B cells converge to an indistinguishable population on signalling through B-cell receptors and CD40.

Authors:  A Gagro; N McCloskey; A Challa; M Holder; G Grafton; J D Pound; J Gordon
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

5.  Increased CD5-positive B lymphocytes in type I diabetes.

Authors:  A Muñoz; T Gallart; O Viñas; R Gomis
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

6.  Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus.

Authors:  Y Ueki; I S Goldfarb; N Harindranath; M Gore; H Koprowski; A L Notkins; P Casali
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

7.  Immunoglobulin and cytokine production by neonatal lymphocytes.

Authors:  W Watson; K Oen; R Ramdahin; C Harman
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

8.  The study of circulating CD5 positive B lymphocytes in Chinese patients with rheumatoid arthritis.

Authors:  S T Liu; C R Wang; M F Liu; J S Li; H Y Lei; C Y Chuang
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

9.  Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM.

Authors:  A Muñoz; T Gallart; E F Usac; J Fernández-Alvarez; O Viñas; N Somoza; J Barceló; R Gomis
Journal:  Diabetologia       Date:  1995-01       Impact factor: 10.122

Review 10.  Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus.

Authors:  Annett M Jacobi; Betty Diamond
Journal:  J Exp Med       Date:  2005-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.